GILEAD SCIENCES, INC. (GILD)

Every figure this model derived for GILD, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 609,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 3,179,000,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 13,945,000,000 AssetsCurrent 2026-06-30
current liabilities 11,020,000,000 LiabilitiesCurrent 2026-06-30
equity 11,829,000,000 StockholdersEquity 2026-06-30
interest expense 998,000,000 InterestExpenseNonoperating 2026-06-30
ocf 13,552,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 30,457,000,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 909,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up GILD on one particular measure came for.

RatioValue
cash operating margin-4.0
current ratio1.27
current ratio reported1.27
deferred revenue growth-53.69
dilution pct0.0
ev owner earnings17.46
ev sales6.9
fcf margin42.5
growth cv1.14
interest cover-2.5
operating margin-8.2
owner earnings margin39.51
revenue growth5.52
revenue growth per share5.52
roic-5.29
rule of 40-2.68
sbc pct revenue2.98

What to be careful about

What this model itself distrusts about GILD's figures. Written by the derivation as it ran, not added afterwards.